Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1980 Oct;77(10):6175–6178. doi: 10.1073/pnas.77.10.6175

Cord-blood tyrosine levels in the full-term phenylketonuric fetus and the "justification hypothesis".

C R Scriver, D E Cole, S A Houghton, H L Levy, A Grenier, C Laberge
PMCID: PMC350237  PMID: 6934544

Abstract

The "justification hypothesis" attributes mental retardation in phenylketonuria (PKU) to an inability of the heterozygous mother to deliver an appropriate amount of tyrosine to the PKU fetus who, in turn, is unable to correct for this deficiency because of its genetic constitution. We tested this hypothesis by measuring concentrations of tyrosine and phenylalanine in cord blood obtained at delivery from nine infants with PKU and five infants with persistent (non-PKU) hyperphenylalaninemia (PHP). For each of these specimens there were four control cord-blood specimens from infants born on the same day and, generally, in the same hospital. PKU and PHP groups were similar with respect to cord-blood tyrosine and phenylalanine values. There was no biologically significant deficiency of tyrosine in cord blood of the pooled PKU and PHP deficiency of tyrosine in cord blood of the pooled PKU and PHP groups (54 +/- 10 microM, mean +/- SD) compared with controls (61 +/- 16 microM, P = 0.13). On the other hand, phenylalanine in cord blood of the pooled PKU and PHP groups was significantly increased (144 +/- 30 microM, mean +/- SD) compared with controls (128 +/- 24, P = 0.004). The mangitude of the differences in cord-blood tyrosine and phenylalanine between control and PKU subjects are so small that it is unlikely that they have any consequences for physical and mental development. The justification hypothesis, as it pertains to blood tyrosine at term, is not upheld.

Full text

PDF
6175

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berman J. L., Ford R. Intelligence quotients and intelligence loss in patients with phenylketonuria and some variant states. J Pediatr. 1970 Nov;77(5):764–770. doi: 10.1016/s0022-3476(70)80233-5. [DOI] [PubMed] [Google Scholar]
  2. Berry H. K., Poncet I. B., Sutherland B. S., Burkett R. Serum amino acid concentrations during pregnancy of women heterozygous for phenylketonuria. Biol Neonate. 1975;26(1-2):102–108. doi: 10.1159/000240721. [DOI] [PubMed] [Google Scholar]
  3. Bessman S. P. Genetic failure of fetal amino acid "justification": a common basis for many forms of metabolic, nutritional, and "nonspecific" mental retardation. J Pediatr. 1972 Oct;81(4):834–842. doi: 10.1016/s0022-3476(72)80117-3. [DOI] [PubMed] [Google Scholar]
  4. Bessman S. P. The justification theory: the essential nature of the non-essential amino acids. Nutr Rev. 1979 Jul;37(7):209–220. doi: 10.1111/j.1753-4887.1979.tb06668.x. [DOI] [PubMed] [Google Scholar]
  5. Bessman S. P., Williamson M. L., Koch R. Diet, genetics, and mental retardation interaction between phenylketonuric heterozygous mother and fetus to produce nonspecific diminution of IQ: evidence in support of the justification hypothesis. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1562–1566. doi: 10.1073/pnas.75.3.1562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cowie V. A. Changes in the heterozygotes for pku and their possible relationship to the environment in utero. Ir Med J. 1976 Sep 30;69(15):401–404. [PubMed] [Google Scholar]
  7. Danks D. M., Cotton R. G., Schlesinger P. Diagnosis of malignant hyperphenylalaninaemia. Arch Dis Child. 1979 May;54(5):329–330. doi: 10.1136/adc.54.5.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dobson J. C., Kushida E., Williamson M., Friedman E. G. Intellectual performance of 36 phenylketonuria patients and their nonaffected siblings. Pediatrics. 1976 Jul;58(1):53–58. [PubMed] [Google Scholar]
  9. FISCH R. O., SINES L. K., TORRES F., ANDERSON J. A. STUDIES ON FAMILIES OF PHENYLKETONURICS: OBSERVATIONS ON INTELLIGENCE AND ELECTROENCEPHALOGRAPHIC CHANGES. Am J Dis Child. 1965 May;109:427–431. doi: 10.1001/archpedi.1965.02090020429008. [DOI] [PubMed] [Google Scholar]
  10. Ford R. C., Berman J. L. Phenylalanine metabolism and intellectual functioning among carriers of phenylketonuria and hyperphenylalaninaemia. Lancet. 1977 Apr 9;1(8015):767–771. doi: 10.1016/s0140-6736(77)92955-5. [DOI] [PubMed] [Google Scholar]
  11. Fujimoto A., Crawford R., Bessman S. P. Relative inability of mother and child to convert phenylalanine of tyrosine--a possible cause of nonspecific mental retardation. Biochem Med. 1979 Jun;21(3):271–276. doi: 10.1016/0006-2944(79)90082-6. [DOI] [PubMed] [Google Scholar]
  12. Fuller R., Shuman J. Treated phenylketonuria: intelligence and blood phenylalanine levels. Am J Ment Defic. 1971 Mar;75(5):539–545. [PubMed] [Google Scholar]
  13. Grenier A., Laberge C. A modified automated fluorometric method for tyrosine determination in blood spotted on paper: a mass screening procedure for tyrosinemia. Clin Chim Acta. 1974 Nov 20;57(1):71–75. doi: 10.1016/0009-8981(74)90179-x. [DOI] [PubMed] [Google Scholar]
  14. Griffin R. F., Humienny M. E., Hall E. C., Elsas L. J. Classic phenylketonuria: heterozygote detection during pregnancy. Am J Hum Genet. 1973 Nov;25(6):646–654. [PMC free article] [PubMed] [Google Scholar]
  15. Holtzman N. A., Welcher D. W., Mellits E. D. Termination of restricted diet in children with phenylketonuria: a randomized controlled study. N Engl J Med. 1975 Nov 27;293(22):1121–1124. doi: 10.1056/NEJM197511272932204. [DOI] [PubMed] [Google Scholar]
  16. Levy H. L. Genetic screening. Adv Hum Genet. 1973;4:1–104. doi: 10.1007/978-1-4615-8261-8_1. [DOI] [PubMed] [Google Scholar]
  17. Rothman K. J., Pueschel S. N. Birthweight of children with phenylketonuria. Pediatrics. 1976 Dec;58(6):842–844. [PubMed] [Google Scholar]
  18. Saugstad L. F. Birthweights in children with phenylketonuria and in their siblings. Lancet. 1972 Apr 15;1(7755):809–813. doi: 10.1016/s0140-6736(72)90797-0. [DOI] [PubMed] [Google Scholar]
  19. Scriver C. R., Laberge C., Clow C. L., Fraser F. C. Genetics and Medicine: an evolving relationship. Science. 1978 May 26;200(4344):946–952. doi: 10.1126/science.644337. [DOI] [PubMed] [Google Scholar]
  20. Smith I., Carter C. O., Wolfe O. H. Birthweight of infants with phenylketonuria and their unaffected siblings. J Inherit Metab Dis. 1978;1(3):99–100. doi: 10.1007/BF01805681. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES